COMPANY PROFILE

EBR Systems

Explore full profile

Develops devices for the treatment of cardiac arrhythmias

Sunnyvale, United StatesFounded 2003Biotech & Life Sciences

Valuation $169M Market cap · 2026

Revenue $1.6M Latest reported FY

Total funding $100–500M Disclosed equity funding

About EBR Systems

EBR Systems, Inc. specializes in developing advanced wireless cardiac pacing systems aimed at improving the treatment of heart failure. The company operates in the medical device market, focusing on Cardiac Resynchronization Therapy (CRT) for patients who require synchronized heart chamber pumping to alleviate heart failure symptoms. EBR Systems' core product, the WiSE CRT System, delivers pacing stimulation directly to the inside of the left ventricle without the need for a wire lead, offering a tailored therapy solution that meets individual patient needs. This innovative approach not only enhances treatment outcomes but also reduces complications associated with traditional wired systems.

Read full description

The company primarily serves healthcare providers and patients suffering from heart failure, offering a cutting-edge solution that addresses the limitations of existing CRT technologies. EBR Systems generates revenue through the sale of its WiSE CRT System to hospitals and medical institutions, leveraging its strong team with extensive experience in medical device development and commercialization.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2003
Headquarters: Sunnyvale, United States
Listing: IPO 2021
Employees: 158
Open positions: 13
Dealroom signal: 93.8/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Risk Management, Biotechnology, medical implants, Cardiology and cardiovascular, Immersive Technologies, Tech for Patients, Hard Tech
Technology: Deep Tech, Augmented Reality
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning EBR Systems.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
POST IPO EQUITYOther financing	Jun 2026	$97M	$208M	Brandon Capital Partners	↗
POST IPO EQUITYOther financing	Jun 2025	$13M	—	Undisclosed	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin
2026	$1.6M	0%	−$43M	-2639%
2025	$1.6M	—	−$43M	-2639%
2024	$0	—	−$34M	—
2023	$0	—	−$25M	—
2022	—	—	−$24M	—
2021	—	—	−$9.6M	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

EBR Systems website traffic

Latest recorded traffic for EBR Systems is 5.3K monthly website visits, up 32.5% over the last three months. EBR Systems's team grew 15.3% over the past year.

Latest monthly visits5.3K 3-month web change+32.5% 1-year team growth+15.3%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Field Clinical Specialist - AtlantaAtlanta, Georgia, United States, Northern America, Americas · Other · Sep 4, 2026 Senior Regulatory Affairs SpecialistSanta Clara, California, United States, Northern America, Americas · Legal · Sep 4, 2026 Field Clinical Specialist - PhoenixPhoenix, Arizona, United States, Northern America, Americas · Other · Sep 4, 2026 Senior Regulatory Affairs SpecialistSunnyvale, CA · Legal · Sep 1, 2026 Training Program ManagerValley, Alabama, United States, Northern America, Americas · Project Management · Aug 28, 2026 Clinical Program ManagerUnited States, Sunnyvale · Other · Aug 28, 2026 Senior QA PMS Clinical Analyst/LeadSanta Clara, California, United States, Northern America, Americas · Business Intelligence · Aug 13, 2026 Product ManagerSanta Clara, CA · Business Development · Aug 2, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
XEXeltisRestorative cardiovascular devices enabling natural tissue regeneration.	Eindhoven, Netherlands	Operational	83	$203M	$90M
VTVectorious Medical TechnologiesDeveloped an in-heart microcomputer that monitors the heart’s left atrium pressure, thereby enabling optimal treatment of heart disease patient	Tel Aviv-Yafo, Israel	Acquired
SISimbionixProvides simulation, training, and education solutions for medical professionals and the healthcare industry	Lod, Israel	Acquired
VOVoluntisHealthcare software company	Suresnes, France	Acquired
KHKjaya HoldingsCloud-based medical imaging management and visualization suite	Stamford, United States	Operational
FEFemasysFemasys is engaged in R&D and manufacture of medical devices for women's healthcare	Suwanee, United States	Operational
ALAlioWearable technology company enabling greater insights through clinical grade real-time data	Menlo Park, United States	Operational
ISInovytec Medical SolutionsInnovative solutions for out-of-hospital medical emergencies, enhancing survivability with advanced airway management and portable ventilators	Ra'anana, Israel	Operational